| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 1997;96:4044-4049.)
© 1997 American Heart Association, Inc.
Articles |
Intrapericardial Delivery of L-Arginine Reduces the Increased Severity of Ventricular Arrhythmias During Sympathetic Stimulation in Dogs With Acute Coronary Occlusion
Nitric Oxide Modulates Sympathetic Effects on Ventricular Electrophysiological Properties
From the Krannert Institute of Cardiology and the Endocrine Division, Department of Medicine, Indiana University School of Medicine, and the Roudebush Veterans Administration Medical Center, Indianapolis, Ind.
Correspondence to Douglas P. Zipes, MD, Distinguished Professor of Medicine, Pharmacology and Toxicology, Krannert Institute of Cardiology, Indiana University Medical Center, 1111 West 10th St, Indianapolis, IN 46202-4800.
Background Nitric oxide (NO) modulates autonomic effects on myocardial contractility and sinus and atrioventricular nodal function of the heart. Whether NO influences autonomic actions on ventricular electrophysiological properties and arrhythmogenesis is not known.
Methods and Results Four groups consisting of 43 autonomically denervated dogs were studied. To "superfuse" sympathetic nerves innervating the ventricles, test drugs were introduced into the pericardial sac for 30 minutes, and their effects on ventricular effective refractory period (ERP) and arrhythmia development were assessed before and during sympathetic stimulation (SS). In group 1 (n=12), ventricular ERPs showed no significant difference between control and superfusion with L-arginine, a NO precursor (222±20 versus 222±19 ms, P=.485). However, L-arginine significantly reduced SS-induced ERP shortening compared with control (9±7 versus 13±7 ms, P<.001). Simultaneous administration of NG-monomethyl-L-arginine (2 mg/mL) abolished the inhibitory effects of L-arginine (13±7 versus 13±7 ms, P=.885). In group 2 (n=15), the severity of ventricular arrhythmias significantly increased during SS. L-Arginine reduced this increase caused by SS. In group 3 (n=8), plasma norepinephrine spillover measured from the coronary sinus significantly increased during SS and was reduced by pericardial superfusion with L-arginine compared with control (6005.2±1525.6 versus 8503.4±2044.5 pg/min, P=.012). In group 4 (n=8), L-arginine pericardial superfusion significantly increased NO overflow measured from the coronary sinus during SS (93.25±59.20 versus 114.82±74.92 nmol/min, P=.043).
Conclusions Pericardial L-arginine reduces ERP shortening and increased severity of ischemic ventricular arrhythmias during SS in dogs. NO-induced reduction of norepinephrine release in the heart may be one of the underlying mechanisms.
Key Words: arrhythmia • nervous system, autonomic • electrophysiology • norepinephrine
This article has been cited by other articles:
 |
|
 |
|
  K. E. Brack, V. H. Patel, J. H. Coote, and G. A. Ng Nitric oxide mediates the vagal protective effect on ventricular fibrillation via effects on action potential duration restitution in the rabbit heart J. Physiol., September 1, 2007; 583(2): 695 - 704. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Sun, F. M. Sanchez, V. Crisostomo, L. Luis, J. Uson, and M. Maynar Subxiphoid Access to Normal Pericardium with Micropuncture Set: Technical Feasibility Study in Pigs Radiology, December 21, 2005; (2005) 2382042182. [Abstract] [Full Text]
|
|
|
|
 |
|
 P.B. Massion, O. Feron, C. Dessy, and J.-L. Balligand Nitric Oxide and Cardiac Function: Ten Years After, and Continuing Circ. Res., September 5, 2003; 93(5): 388 - 398. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kumar, K. Nguyen, S. Waxman, B. D. Nearing, G. A. Wellenius, S. X. Zhao, and R. L. Verrier Potent antifibrillatory effects of intrapericardial nitroglycerin in the ischemic porcine heart J. Am. Coll. Cardiol., May 21, 2003; 41(10): 1831 - 1837. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. L. Brutsaert Cardiac Endothelial-Myocardial Signaling: Its Role in Cardiac Growth, Contractile Performance, and Rhythmicity Physiol Rev, January 1, 2003; 83(1): 59 - 115. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Rubart and D. P. Zipes NO Hope for Patients With Atrial Fibrillation Circulation, November 26, 2002; 106(22): 2764 - 2766. [Full Text] [PDF]
|
|
|
|
 |
|
 A. M Dart, X.-J. Du, and B. A Kingwell Gender, sex hormones and autonomic nervous control of the cardiovascular system Cardiovasc Res, February 15, 2002; 53(3): 678 - 687. [Full Text] [PDF]
|
|
|
|
|
|
B. D. Hoit Two Faces of Nitric Oxide: Lessons Learned From the NOS2 Knockout Circ. Res., August 17, 2001; 89(4): 289 - 291. [Full Text] [PDF]
|
|
|
|
|
|
R.M Mohan, J.K Choate, S Golding, N Herring, B Casadei, and D.J Paterson Peripheral pre-synaptic pathway reduces the heart rate response to sympathetic activation following exercise training: role of NO Cardiovasc Res, July 1, 2000; 47(1): 90 - 98. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-L. Balligand Regulation of cardiac {beta}-adrenergic response by nitric oxide Cardiovasc Res, August 15, 1999; 43(3): 607 - 620. [Full Text] [PDF]
|
|
|
|
|
|
S. Waxman, R. Moreno, K. A. Rowe, and R. L. Verrier Persistent primary coronary dilation induced by transatrial delivery of nitroglycerin into the pericardial space: a novel approach for local cardiac drug delivery J. Am. Coll. Cardiol., June 1, 1999; 33(7): 2073 - 2077. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. L. Verrier, S. Waxman, E. G. Lovett, and R. Moreno Transatrial Access to the Normal Pericardial Space : A Novel Approach for Diagnostic Sampling, Pericardiocentesis, and Therapeutic Interventions Circulation, November 24, 1998; 98(21): 2331 - 2333. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. P. Zipes and H. J. J. Wellens Sudden Cardiac Death Circulation, November 24, 1998; 98(21): 2334 - 2351. [Full Text] [PDF]
|
|